Skip to main content

Advertisement

SpringerLink
Log in

HIV and Cardiovascular Disease: The Impact of Cigarette Smoking

  • Smoking (Hilary A. Tindle, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

The era of combination antiretroviral therapy (cART) has resulted in longer life expectancy for HIV-infected individuals, leaving them at greater risk of developing chronic illnesses such as cardiovascular disease (CVD). Tobacco use is an important modifiable risk factor for CVD events; however, our ability to promote successful cessation among people living with HIV/AIDS (PLWHA) remains limited. Barriers such as co-occurring substance use disorders, mental health conditions, and low socioeconomic status present many challenges to sustained smoking abstinence. Additional strategies must be implemented to improve quit rates in the HIV-infected population and further research is needed to inform approaches. In this article, we examine the contribution of HIV and cigarette smoking to CVD risk, and summarize the data on smoking behaviors and efforts to improve tobacco cessation among PLWHA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •Of importance

  1. Palella Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–60.

    Article  PubMed  Google Scholar 

  2. • Smith C. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010;24(10):1537–48. The decreasing trend in mortality among the HIV-infected population was found to continue, according to results from the DAD Study. The overall rate of death per 1000 person-years fell from 16.9 in 1999/2000 to 9.6 in 2007/2008. Although cART was observed to be associated with this reduction in mortality, the primary cause of death in this cohort was AIDS-related, followed by liver-related, CVD-related, and non-AIDS malignancies.

    PubMed  Google Scholar 

  3. Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med. 2005;118(8):890–8.

    Article  PubMed  Google Scholar 

  4. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41(2):194–200.

    Article  PubMed  Google Scholar 

  5. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6(2):99–106.

    Article  PubMed  CAS  Google Scholar 

  6. Currier JS. Update on cardiovascular complications in HIV infection. Top HIV Med. 2009;17(3):98–103.

    PubMed  Google Scholar 

  7. Rickerts V, Brodt H, Staszewski S, Stille W. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res. 2000;5(8):329–33.

    PubMed  CAS  Google Scholar 

  8. Holmberg SD, Moorman AC, Williamson JM, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet. 2002;360(9347):1747–8.

    Article  PubMed  CAS  Google Scholar 

  9. Niaura R, Shadel WG, Morrow K, et al. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31(3):808–12.

    Article  PubMed  CAS  Google Scholar 

  10. Burkhalter JE, Springer CM, Chhabra R, et al. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511–22.

    Article  PubMed  Google Scholar 

  11. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30(5):371–83.

    Article  PubMed  Google Scholar 

  12. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation. 1997;96(9):3243–7.

    PubMed  CAS  Google Scholar 

  13. Ford ES, Greenwald JH, Richterman AG, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS. 2010;24(10):1509–17.

    Article  PubMed  Google Scholar 

  14. • Lifson AR, Neuhaus J, Arribas JR, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health 2010;100(10):1896–903. In this original article published by the SMART Study, adjusted hazard ratios were evaluated in current smokers. AHRs in current smokers were significantly higher in overall mortality, major CVD, non-AIDS cancers, and bacterial pneumonia when compared with former and never smokers. Therefore, smoking contributes to considerable morbidity and mortality in the HIV-infected population.

    Article  PubMed  Google Scholar 

  15. • Cockerham L, Scherzer R, Zolopa A, et al. Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr. 2010;53(1):102–6. This study examined overall adjusted mortality hazard ratios in the HIV-infected population in the current cART era. HIV-infection was associated with a threefold mortality risk compared to controls, whereas baseline CD4+ count, older age, and current smoking were found to be strong independent predictors of mortality.

    Article  PubMed  Google Scholar 

  16. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev. 2009;21(3 Suppl):40–53.

    Article  PubMed  Google Scholar 

  17. Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20(12):1142–5.

    Article  PubMed  Google Scholar 

  18. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003;46(1):11–29.

    Article  PubMed  Google Scholar 

  19. Cavender JB, Rogers WJ, Fisher LD, et al. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol. 1992;20(2):287–94.

    Article  PubMed  CAS  Google Scholar 

  20. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2004(1):CD003041.

  21. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368(9536):647–58.

    Article  PubMed  Google Scholar 

  22. • Mannan HR, Stevenson CE, Peeters A, et al. Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking. Heart International 2010;5(e11):49–57. In this study, incorporating time since quitting among past smokers and pack-years among current smokers in CVD risk models resulted in better predictive performance, compared with a dichotomous current smoker/nonsmoker measure or a current/former/never smoker measure in HIV-uninfected populations.

    Google Scholar 

  23. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA. 1995;274(2):155–60.

    Article  PubMed  CAS  Google Scholar 

  24. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med. 1985;313(24):1511–4.

    Article  PubMed  CAS  Google Scholar 

  25. Honjo K, Iso H, Tsugane S, et al. The effects of smoking and smoking cessation on mortality from cardiovascular disease among Japanese: pooled analysis of three large-scale cohort studies in Japan. Tob Control. 2010;19(1):50–7.

    Article  PubMed  Google Scholar 

  26. Diez-Roux AV, Nieto FJ, Comstock GW, et al. The relationship of active and passive smoking to carotid atherosclerosis 12–14 years later. Prev Med. 1995;24(1):48–55.

    Article  PubMed  CAS  Google Scholar 

  27. Howard G, Burke GL, Szklo M, et al. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med. 1994;154(11):1277–82.

    Article  PubMed  CAS  Google Scholar 

  28. Barua RS, Ambrose JA, Eales-Reynolds LJ, et al. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation. 2001;104(16):1905–10.

    Article  PubMed  CAS  Google Scholar 

  29. Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol. 1996;28(5):1161–7.

    Article  PubMed  CAS  Google Scholar 

  30. McVeigh GE, Lemay L, Morgan D, Cohn JN. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol. 1996;78(6):668–72.

    Article  PubMed  CAS  Google Scholar 

  31. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide. 2001;5(2):88–97.

    Article  PubMed  CAS  Google Scholar 

  32. Blache D. Involvement of hydrogen and lipid peroxides in acute tobacco smoking-induced platelet hyperactivity. Am J Physiol. 1995;268(2 Pt 2):H679–85.

    PubMed  CAS  Google Scholar 

  33. Burke AP, Farb A, Malcom GT, et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97(21):2110–6.

    PubMed  CAS  Google Scholar 

  34. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336(18):1276–82.

    Article  PubMed  CAS  Google Scholar 

  35. Smith CJ, Fischer TH. Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis. 2001;158(2):257–67.

    Article  PubMed  CAS  Google Scholar 

  36. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med. 1998;3(1):21–8.

    PubMed  CAS  Google Scholar 

  37. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17(10):2167–76.

    Article  PubMed  CAS  Google Scholar 

  38. Bermudez EA, Rifai N, Buring JE, et al. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002;89(9):1117–9.

    Article  PubMed  Google Scholar 

  39. Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997;78(3):273–7.

    PubMed  CAS  Google Scholar 

  40. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci (Lond). 1995;88(4):485–9.

    CAS  Google Scholar 

  41. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Bmj. 1989;298(6676):784–8.

    Article  PubMed  CAS  Google Scholar 

  42. Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol. 2003;41(6):1044–7.

    Article  PubMed  CAS  Google Scholar 

  43. Nishio E, Watanabe Y. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme’s free thiols. Biochem Biophys Res Commun. 1997;236(2):289–93.

    Article  PubMed  CAS  Google Scholar 

  44. Yamaguchi Y, Kagota S, Haginaka J, Kunitomo M. Evidence of modified LDL in the plasma of hypercholesterolemic WHHL rabbits injected with aqueous extracts of cigarette smoke. Environ Toxicol Pharmacol. 2000;8(4):255–60.

    Article  PubMed  CAS  Google Scholar 

  45. Sun YP, Zhu BQ, Browne AE, et al. Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke. Circulation. 2001;104(7):810–4.

    Article  PubMed  CAS  Google Scholar 

  46. Benard A, Bonnet F, Tessier JF, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 aquitaine cohort. AIDS Patient Care STDS. 2007;21(7):458–68.

    Article  PubMed  Google Scholar 

  47. Fuster M, Estrada V, Fernandez-Pinilla MC, et al. Smoking cessation in HIV patients: rate of success and associated factors. HIV Med. 2009;10(10):614–9.

    Article  PubMed  CAS  Google Scholar 

  48. Gritz ER, Vidrine DJ, Lazev AB, et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6(1):71–7.

    Article  PubMed  Google Scholar 

  49. • Marshall MM, Kirk GD, Caporaso NE, et al. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav. 2011;36(1–2):61–7. In this study, smoking behaviors were examined among subjects enrolled in the ALIVE Study. Smoking prevalence, age at smoking initiation, cumulative tobacco exposure, nicotine dependence, and daily cigarette consumption were found to be similar by HIV status. Active injection drug users, however, had a significantly higher smoking prevalence, greater daily consumption, and slightly higher Fagerstrom scores, suggesting concurrent illicit drug addiction as a barrier to cessation.

    Article  PubMed  Google Scholar 

  50. Encrenaz G, Benard A, Rondeau V, et al. Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort. Curr HIV Res. 2010;8(3):212–7.

    Article  PubMed  CAS  Google Scholar 

  51. • Goldberg D, Weber KM, Orsi J, et al. Smoking cessation among women with and at risk for HIV: are they quitting? J Gen Intern Med. 2010;25(1):39–44. In adjusted logistic regression, current and former female users of crack, cocaine, or heroin and those smoking more cigarettes daily were significantly less likely to quit smoking compared to those who never used these substances or who smoked fewer cigarettes each day. Hispanic women were more likely to have sustained cessation than non-Hispanic blacks, and women with more education were more likely to quit smoking. Concurrent addiction behaviors, lower education, and lower socioeconomic status are common in PLWHA and present additional obstacles to sustained cessation.

    Article  PubMed  Google Scholar 

  52. Reynolds NR, Neidig JL, Wewers ME. Illness representation and smoking behavior: a focus group study of HIV-positive men. J Assoc Nurses AIDS Care. 2004;15(4):37–47.

    Article  PubMed  Google Scholar 

  53. • Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14(4):824–35. Analyses of self-administered questionnaire responses from PLWHA and HIV/AIDS service providers in New York State demonstrated that 75% of HIV-infected smokers expressed an interest in quitting. At the same time, 65% of service providers perceived client resistance as a barrier to cessation services, indicating possible failed opportunities to promote smoking cessation in the HIV-infected population.

    Article  PubMed  Google Scholar 

  54. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med. 2007;22(6):749–54.

    Article  PubMed  Google Scholar 

  55. • Shuter J, Salmo LN, Shuter AD, et al. Provider Beliefs and Practices Relating to Tobacco Use in Patients Living with HIV/AIDS: A National Survey. AIDS Behav 2011. Results from a nationwide survey, offered to the entire online HIV Medical Association registry, showed that fewer than 30% of HIV health care providers were ever formally trained in tobacco treatment despite agreeing that smoking is an important issue for PLWHA. Greater training is needed among medical providers to promote smoking cessation strategies in the HIV-infected population.

  56. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS. 2002;16(1):39–42.

    Article  PubMed  Google Scholar 

  57. Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care. 2000;11(6):37–44.

    Article  PubMed  CAS  Google Scholar 

  58. • Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction 2009;104(11):1891–900. Participants in this randomized clinical trial were provided either motivational counseling plus NRT or self-help materials plus NRT. Biochemically confirmed abstinence rates at 2-, 4-, and 6-month follow-up showed no difference between groups. Smoking cessation interventions oftentimes must be multi-pronged to be effective.

    Article  PubMed  Google Scholar 

  59. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3):545–54.

    Article  PubMed  Google Scholar 

  60. Peretti-Watel P, Garelik D, Baron G, et al. Smoking motivations and quitting motivations among HIV-infected smokers. Antivir Ther. 2009;14(6):781–7.

    Article  PubMed  Google Scholar 

  61. Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs Stand. 2005;20(12):41–7.

    PubMed  Google Scholar 

  62. Cupertino AP, Wick JA, Richter KP, et al. The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study. Arch Intern Med. 2009;169(20):1928–30.

    Article  PubMed  Google Scholar 

  63. Ellerbeck EF, Mahnken JD, Cupertino AP, et al. Effect of varying levels of disease management on smoking cessation: a randomized trial. Ann Intern Med. 2009;150(7):437–46.

    PubMed  Google Scholar 

  64. Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20(2):253–60.

    Article  PubMed  Google Scholar 

  65. • Petoumenos K, Worm S, Reiss P, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med 2011. This original article, published by the DAD Study, exhibited the inverse relationship of decreasing CVD incidence with increasing time since stopping smoking. Incidence rate ratios of MI, CHD, and CVD all showed decreasing trends over 3 years of smoke-free follow-up time, exhibiting the benefits of smoking cessation in the HIV-infected population.

  66. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47(4):542–53.

    Article  PubMed  Google Scholar 

Download references

Disclosure

S. Shahrir: none; K. Crothers reports that her institution has received a grant from the National Institutes of Health (NIH/NHLBI 1R01 HL090342).

Author information

Authors and Affiliations

  1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Harborview Medical Center at the University of Washington, Seattle, WA, USA

    Shahida Shahrir & Kristina Crothers

  2. Harborview Medical Center, University of Washington, 325 Ninth Avenue, #359765, Seattle, WA, 98109, USA

    Shahida Shahrir

Authors
  1. Shahida Shahrir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristina Crothers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shahida Shahrir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shahrir, S., Crothers, K. HIV and Cardiovascular Disease: The Impact of Cigarette Smoking. Curr Cardiovasc Risk Rep 5, 492–500 (2011). https://doi.org/10.1007/s12170-011-0197-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12170-011-0197-x

Keywords

Search

Navigation